Esperion Therapeutics | Capitale Di Prestito

Prezzo Delle Azioni
3.49
Cambio Giornaliero
0.10 2.80%
Mensile
-1.83%
Annuale
85.37%
Q1 Previsione
2.70




Capitale Di Prestito Cambiamento Data
AbbVie USD 62.97B 12M 2025-09
Alnylam Pharmaceuticals USD 1.04B 13.75M 2025-09
Alterity Therapeutics Limited AUD 103.21K 73.88K 2023-06
Amgen USD 50B 2.43B 2025-12
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 596.66M 501K 2025-09
Cipla INR 2.98B 454.6M 2025-09
CSL USD 10.69B 1.37B 2025-06
Cytokinetics USD 158.75M 554.3M 2025-09
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Eli Lilly USD 40.87B 6.69B 2025-09
Esperion Therapeutics USD 262.48M 235.95M 2024-06
Geron USD 119.26M 273K 2025-09
Grifols EUR 10.67B 564.4M 2025-09
Halozyme Therapeutics USD 800.07M 709.03M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 28.78M 596.71M 2025-09
Merck USD 39.97B 6B 2025-09
Minerva Neurosciences USD 0 86.58M 2024-09
Moderna USD 26M 6M 2025-09
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 1.84B 298.68M 2025-09
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
Sarepta Therapeutics USD 1.04B 104.31M 2025-09
United Therapeutics USD 100M 100M 2024-06
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12


Esperion Therapeutics Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.